Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franklin Fuda

Showing results (21-30 of 51) with videos related to

Pageof 6
Sort By:
Annals of Diagnostic Pathology|November 5, 2011
Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutationsCharles M Zaremba, Dwight Oliver, Maryellen Cavalier, et al.
Cancer Genetics|October 26, 2022
A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphomaRolando García, Charles Timmons, Hung Luu, et al.
Leukemia Research Reports|May 19, 2022
<i>CSF3R</i> T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profileAdelaide Kwon, Ibrahim Ibrahim, Tri Le, et al.
Seminars in Diagnostic Pathology|February 21, 2023
Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathologyElisa Lin, Franklin Fuda, Hung S Luu, et al.
American Journal of Clinical Pathology|June 23, 2021
LILRB1: A Novel Diagnostic B-Cell Marker to Distinguish Neoplastic B Lymphoblasts From HematogonesSilvia Saumell Tutusaus, Elaina Pirruccello, Franklin Fuda, et al.
Human Pathology|December 8, 2014
Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasmDinesh Rakheja, Franklin Fuda, Travis Vandergriff, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|February 19, 2024
RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic MalignanciesPrasad Koduru, Weina Chen, Franklin Fuda, et al.
American Journal of Clinical Pathology|April 22, 2017
CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative PatientsPu Chen, Andrew Chu, Hamid Zia, et al.
International Journal of Laboratory Hematology|January 4, 2024
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblastsDong Chen, Franklin Fuda, Flavia Rosado, et al.
Ejhaem|October 16, 2025
B/T Mixed Phenotype Acute Leukaemia Harbouring <i>NUP98::BPTF</i> FusionVan Tuong Nguyen, Lina Han, Jing Xu, et al.
Pageof 6

Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Annals of Diagnostic Pathology|November 5, 2011
Distinct immunophenotype of early T-cell progenitors in T lymphoblastic leukemia/lymphoma may predict FMS-like tyrosine kinase 3 mutationsCharles M Zaremba, Dwight Oliver, Maryellen Cavalier, et al.
Cancer Genetics|October 26, 2022
A t(11;14)(q13;q32)/CCND1::IGH carrying progenitor germinal B-cell with subsequent cytogenetic aberrations contributes to the development of classic Hodgkin lymphomaRolando García, Charles Timmons, Hung Luu, et al.
Leukemia Research Reports|May 19, 2022
<i>CSF3R</i> T618I mutated chronic myelomonocytic leukemia: A proliferative subtype with a distinct mutational profileAdelaide Kwon, Ibrahim Ibrahim, Tri Le, et al.
Seminars in Diagnostic Pathology|February 21, 2023
Digital pathology and artificial intelligence as the next chapter in diagnostic hematopathologyElisa Lin, Franklin Fuda, Hung S Luu, et al.
American Journal of Clinical Pathology|June 23, 2021
LILRB1: A Novel Diagnostic B-Cell Marker to Distinguish Neoplastic B Lymphoblasts From HematogonesSilvia Saumell Tutusaus, Elaina Pirruccello, Franklin Fuda, et al.
Human Pathology|December 8, 2014
Increased plasma d-2-hydroxyglutarate in isocitrate dehydrogenase 2-mutated blastic plasmacytoid dendritic cell neoplasmDinesh Rakheja, Franklin Fuda, Travis Vandergriff, et al.
Clinical Pathology (Thousand Oaks, Ventura County, Calif.)|February 19, 2024
RNASeq Analysis for Accurate Identification of Fusion Partners in Tumor Specific Translocations Detected by Standard FISH Probes in Hematologic MalignanciesPrasad Koduru, Weina Chen, Franklin Fuda, et al.
American Journal of Clinical Pathology|April 22, 2017
CD25 Expression in B Lymphoblastic Leukemia/Lymphoma Predicts t(9;22)(q34;q11)/Philadelphia Chromosome Translocation (Ph) and Is Associated With Residual Disease in Ph-Negative PatientsPu Chen, Andrew Chu, Hamid Zia, et al.
International Journal of Laboratory Hematology|January 4, 2024
Clinicopathologic features of relapsed CD19(-) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(-) B lymphoblastsDong Chen, Franklin Fuda, Flavia Rosado, et al.
Ejhaem|October 16, 2025
B/T Mixed Phenotype Acute Leukaemia Harbouring <i>NUP98::BPTF</i> FusionVan Tuong Nguyen, Lina Han, Jing Xu, et al.
Pageof 6